Finance

Lists
ADAG:NASDAQ
Adagene Inc
$3.21
-3.02%
(-0.100) 1D
Sep 21, 3:30:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADAG...
Open
$3.34
High
$3.35
Low
$3.18
Mkt. cap
215.53M
Avg. vol.
251.19K
Volume
65.41K
52-wk high
$4.85
52-wk low
$1.30
EPS
-$0.38
Beta
0.56
Shares outstanding
67.14M
No. of employees
128
Open
$3.34
High
$3.35
Low
$3.18
Mkt. cap
215.53M
Avg. vol.
251.19K
Volume
65.41K
52-wk high
$4.85
52-wk low
$1.30
EPS
-$0.38
Beta
0.56
Shares outstanding
67.14M
No. of employees
128
News stories
From web sources and news partners
About Adagene Inc
CEO-
Employees128
Founded2011
Headquarters-
SectorBiotechnology
Websiteadagene.com
Analyst ratings
Based on 5 analysts giving stock ratings to ADAG in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ADAG in the last 3 months.
Highest
Current $3.21
$10.00 (+211.53%)
Average
$8.50 (+164.80%)
Lowest
$7.00 (+118.07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Arthur He CFA
H.C. Wainwright
Buy
Maintained
$7.00
+118.1%
09/14/2026
Paul Jeng
Guggenheim
Buy
Maintained
$10.00
+211.5%
09/10/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$8.00
+149.2%
09/10/2026
Gautam Chukka
Chardan Capital
Buy
Initiated
$9.00
+180.4%
09/10/2026
Maxwell Skor
Morgan Stanley
Hold
Maintained
-
-
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.84M
3.84M
809.96K
809.96K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.98M
4.98M
6.98M
6.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.73M
1.73M
2.12M
2.12M
Operating expense
6.71M
6.71M
9.10M
9.10M
Total operating expenses
6.71M
6.71M
9.10M
9.10M
Operating income
-2.88M
-2.88M
-8.29M
-8.29M
Other non operating income
154.25K
154.25K
-463.43K
-463.43K
EBT including unusual items
-2.22M
-2.22M
-8.22M
-8.22M
EBT excluding unusual items
-2.22M
-2.22M
-8.22M
-8.22M
Income tax expense
-149.16K
-149.16K
-34.01K
-34.01K
Effective tax rate
6.73%
6.73%
0.41%
0.41%
Other operating expenses
-
-
-
-
Net income
-2.07M
-2.07M
-8.19M
-8.19M
Net profit margin
-53.87%
-53.87%
-1,011.09%
-1,011.09%
Earnings per share
-
-
-
-
Interest and investment income
544.94K
544.94K
688.39K
688.39K
Interest expense
-72.36K
-72.36K
-70.17K
-70.17K
Net interest expenses
472.59K
472.59K
618.22K
618.22K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.77M
-2.77M
-8.21M
-8.21M
Gain or loss from assets sale
573.00
573.00
-1.61K
-1.61K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps